149 related articles for article (PubMed ID: 24411913)
1. Multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation in a Noonan syndrome patient with hypertrophic obstructive cardiomyopathy.
Maekawa Y; Jinzaki M; Tsuruta H; Yamada Y; Kishino Y; Kawakami T; Hayashida K; Yuasa S; Murata M; Kawamura A; Sano M; Kuribayashi S; Fukuda K
Int J Cardiol; 2014; 172(1):e79-81. PubMed ID: 24411913
[No Abstract] [Full Text] [Related]
2. Successful second attempt multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation for an octogenarian with hypertrophic obstructive cardiomyopathy.
Maekawa Y; Jinzaki M; Anzai A; Tsuruta H; Matsumura K; Yamada Y; Tabei R; Kawakami T; Hayashida K; Yuasa S; Murata M; Suzuki M; Kuribayashi S; Fukuda K
Int J Cardiol; 2014 Oct; 176(3):e131-2. PubMed ID: 25150473
[No Abstract] [Full Text] [Related]
3. Utility of the reverse wire technique in multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation.
Maekawa Y; Jinzaki M; Anzai A; Matsumura K; Tsuruta H; Kawakami T; Hayashida K; Yuasa S; Murata M; Suzuki M; Kuribayashi S; Fukuda K
Int J Cardiol; 2014 May; 173(3):e33-4. PubMed ID: 24708931
[No Abstract] [Full Text] [Related]
4. Improved renal function in a patient with hypertrophic obstructive cardiomyopathy after multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation.
Maekawa Y; Jinzaki M; Tsuruta H; Akita K; Yamada Y; Kawakami T; Hayashida K; Yuasa S; Murata M; Fukuda K
Int J Cardiol; 2015 Feb; 181():349-50. PubMed ID: 25555276
[No Abstract] [Full Text] [Related]
5. Percutaneous transluminal septal myocardial ablation in a child with hypertrophic obstructive cardiomyopathy and Noonan syndrome.
Singh H; Kalra R; Keshavamurthy GB; Singh M; Singh C
Congenit Heart Dis; 2008; 3(5):347-51. PubMed ID: 18837814
[TBL] [Abstract][Full Text] [Related]
6. [Comparable effects of percutaneous transluminal septal myocardial ablation and subaortic ventriculotomy in treating patients with hypertrophic obstructive cardiomyopathy, an echocardiography follow-up study].
Li J; Liu YL; He Q; Qiao SB; Feng W; Lü XZ; Zhu ZH; Ling Y; Wang JP
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):695-8. PubMed ID: 17081391
[TBL] [Abstract][Full Text] [Related]
7. [Prenatal hypertrophic cardiomyopathy and neonatal noonan syndrome: an association to remember].
Sánchez Andrés A; Moriano Gutiérrez A; Carrasco Moreno JI
Rev Esp Cardiol; 2011 Jun; 64(6):537-8. PubMed ID: 21397377
[No Abstract] [Full Text] [Related]
8. Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Okayama S; Uemura S; Soeda T; Horii M; Saito Y
J Cardiovasc Comput Tomogr; 2010; 4(1):62-5. PubMed ID: 19914881
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of multi-detector row computed tomography for the management of percutaneous transluminal septal myocardial ablation in patient with hypertrophic obstructive cardiomyopathy.
Mitsutake R; Miura S; Sako H; Nishikawa H; Saku K
Int J Cardiol; 2008 Sep; 129(2):e61-3. PubMed ID: 17888532
[TBL] [Abstract][Full Text] [Related]
10. Multidetector computerized tomography can guide and document alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Ghersin E; Soto V; Heldman AW
Circulation; 2011 Jan; 123(2):e5-7. PubMed ID: 21242503
[No Abstract] [Full Text] [Related]
11. Unroofing of Myocardial Bridging After Septal Myectomy in a Child With Noonan Syndrome.
Said SM; Marey G; Hiremath GM
World J Pediatr Congenit Heart Surg; 2021 Sep; 12(5):659-660. PubMed ID: 32772794
[TBL] [Abstract][Full Text] [Related]
12. Systolic anterior motion of the posterior mitral leaflet in obstructive hypertrophic cardiomyopathy with Noonan syndrome.
Koide M; Kyodo A; Fukui K; Irie D; Matsuo A; Akabame S
J Echocardiogr; 2021 Dec; 19(4):260-262. PubMed ID: 32462482
[No Abstract] [Full Text] [Related]
13. [Percutaneous transluminal septal myocardial ablation combined with permanent dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a case report].
Ochiai N; Furukawa K; Ebizawa T; Yagi T; Akashi K; Azuma A; Nakagawa M
J Cardiol; 2000 Nov; 36(5):331-6. PubMed ID: 11107555
[TBL] [Abstract][Full Text] [Related]
14. [Myocardial perfusion evaluation post percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy by ⁹⁹Tc(m) MIBI SPECT MPI].
Sun XX; Tian YQ; Qiao SB; Yuan JS; Duan FJ; Wang DY; Guo F; He ZX
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):497-502. PubMed ID: 21924073
[TBL] [Abstract][Full Text] [Related]
15. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
Pedone C; Biagini E; Galema TW; Vletter WB; ten Cate FJ
J Am Soc Echocardiogr; 2006 Aug; 19(8):982-6. PubMed ID: 16880092
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous transcoronary septal ablation: a promising modality for treatment of hypertrophic obstructive cardiomyopathy.
Gambhir DS; Singh S
Indian Heart J; 1999; 51(4):379-80, 409. PubMed ID: 10547935
[No Abstract] [Full Text] [Related]
17. Improved blood flow after percutaneous transluminal septal myocardial ablation visualized by 4D flow cardiac magnetic resonance in a case of hypertrophic obstructive cardiomyopathy.
Suwa K; Akita K; Iguchi K; Sugiyama M; Maekawa Y
Eur Heart J Cardiovasc Imaging; 2018 Dec; 19(12):1389. PubMed ID: 30202957
[No Abstract] [Full Text] [Related]
18. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy.
Kar S; Makkar R
Rev Cardiovasc Med; 2001; 2(2):97-102. PubMed ID: 12439386
[TBL] [Abstract][Full Text] [Related]
19. Long-term electrocardiographic findings in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
Haghjoo M
J Electrocardiol; 2007 Oct; 40(4):357.e1-2. PubMed ID: 17599476
[No Abstract] [Full Text] [Related]
20. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
Cheng TO
Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
